Motherhood Delayed, Not Denied
This is the May 22nd issue of the ForbesBLK newsletter, dedicated to elevating and empowering the world's top Black entrepreneurs, leaders and investors. Delivered every Thursday straight to your inbox, it's a must-read for those looking to stay inspired. Click here to get on the newsletter list!
Hey ForbesBLK. Ayisha Mendez here.
According to the Centers for Disease Control and Prevention, for the first time in U.S. history, more babies are being born to women over 40 than to teenagers. While that trend may not be shocking, what continues to stun is the persistence of the motherhood penalty—the measurable career and income sacrifices women make when they become mothers.
Recently, I sat down with Erica Cobb, a TV and podcast host whose latest project, Fertility Unfiltered sheds light on her deeply personal journey with infertility. It's a challenge that affects Black women at nearly twice the rate of white women, according to the American Society of Reproductive Medicine.
In our conversation, Cobb, the CEO of digital media company ComebackTV, recalls a pivotal moment early in her career. She landed a dream job, only to overhear leadership suggesting that a future co-worker on maternity leave was no longer needed as Cobb had filled an adjacent role. That moment, Cobb says, revealed the quiet calculations that too often sideline mothers in the workplace. It also impacted her decision to prioritize a career before motherhood.
Erica Cobb
According to the Institute For Women's Policy Research, 'motherhood accounts for nearly 80% of the gender pay gap in the U.S.' Add to that systemic discrimination, career drop-offs, burnout, and soaring childcare costs – it's clear: the professional world still hasn't made room for working mothers, causing many women to delay motherhood.
'It's not too late,' Cobb says. 'You can have both.'
Thanks to science, advances in modern medicine, and accessible family planning, women are gaining more agency over when and how they choose to build a family without sacrificing their professional ambitions. Still, at its core, Cobb's mission is clear: to help women feel less alone, stay more informed, and be empowered to advocate for the lives and careers they deserve.
Check out the full interview here.
Until next time, stay connected with me on LinkedIn and Instagram!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
CDC backtracks on layoffs, rehires more than 400 people
The Centers for Disease Control and Prevention is reinstating more than 400 people who had received layoff notices, according to an email from CDC leadership to employees seen by POLITICO. The rehiring, announced internally today, marks the largest number of employees that the agency has asked back to date. Around half of those employees are in the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention, and around a third are in the National Center for Environmental Health. Other divisions seeing reinstatements include the National Center for Health Statistics, Center for Forecasting and Outbreak Analytics, Office of Human Resources, Global Health Center, Office of Acquisition Services and Office of Communications. HHS spokesperson Andrew Nixon did not immediately respond to a request for comment. He told Fox News, which first reported the news: 'The Trump Administration is committed to protecting essential services — whether it's supporting coal miners and firefighters through [the National Institute for Occupational Safety and Health], safeguarding public health through lead prevention, or researching and tracking the most prevalent communicable diseases.' — Key context: In April, roughly 2,400 CDC employees received termination notices amid a massive reorganization of the Department of Health and Human Services. But the agency has periodically rehired staff over the past few months.
The Hill
41 minutes ago
- The Hill
What to know about the new ‘Nimbus' COVID variant
The World Health Organization is keeping an eye on a new COVID-19 variant called NB.1.8.1, or 'Nimbus,' that has spread across Europe, the Americas and the Western Pacific. Nimbus is a descendant of the Omicron variant of the virus and was first identified in late January. Its spike mutations appear to make it more transmissible than other COVID variants, according to the WHO. Spike mutations refer to changes in spike proteins, which sit on the surface of the virus and help it enter healthy cells. While it is spreading in the U.S. and Canada, along with 20 other countries, it does not appear to be driving an increase in sickness or hospitalization. In April, NB.1.8.1 sequences made up 10.7 percent of all submitted sequences from confirmed COVID infections, up from 2.5 percent a month earlier, according to a risk evaluation released by the WHO. The WHO last month deemed NB.1.8.1 a variant 'under monitoring.' Here's what to know about the variant. Most cases of COVID-19 in the U.S. still stem from the LP.8.1 strain, another Omicron descendant. But it looks like NB.1.8.1 might soon replace it as the more common strain, according to data from the Centers for Disease Control and Prevention (CDC). The CDC estimates that 37 percent of COVID-19 cases in the U.S. stem from the NB.1.8.1 variant while 38 percent are a result from an infection of the LP.8.1 strain of the disease. At the end of May, the agency estimated that the NB.1.8.1 variant caused about 15 percent of all COVID cases. But the agency notes on its website that due to low numbers of virus sequences being reported, precision in the most recent reporting period is low. The NB.1.8.1 variant has been found in at least 13 states, according to Today, which cited data from the Global Initiative on Sharing All Influenza Data (GISAID) database. Those states are: California, New York, New Jersey, Maryland, Arizona, Illinois, Hawaii, Massachusetts, Ohio, Rhode Island, Vermont, Virginia and Washington. The available data on 'Nimbus' suggests that it poses a low global threat and that existing COVID-19 vaccines provide adequate protection against severe illness and hospitalization, according to the WHO. 'Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease,' reads the WHO's risk evaluation. 'Despite a concurrent increase in cases and hospitalizations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation.' Lionel Gesh, an international consultant at the WHO, told The Hill that many new cases in Canada are likely linked to the NB.1.8.1 variant, but that there has not been any major changes in the country in terms of cases, hospitalizations, ICU admissions or deaths linked to COVID-19. Symptoms of NB.1.8.1 seem to be similar to those associated with other Omicron variants, according to Gresh. Some common COVID-19 symptoms include cough, fever, fatigue, muscle aches, congestion, headache, nausea, vomiting, and a new loss of smell or taste, according to the CDC. 'We should be as concerned about [NB.1.8.1] as we are concerned for COVID in general,' Gesh said. 'Not more, not less.' Some recent COVID-19 patients have reported experiencing something called 'razor blade throat,' according to Salon. But it is unclear if that symptom is connected to one of the COVID variants or another respiratory illness circulating, Ryan Gregory, an evolutionary and genome biologist at the University of Guelph in Canada, told the outlet.
USA Today
43 minutes ago
- USA Today
Unpacking RFK's lengthy social media post after firing vaccine committee members
Unpacking RFK's lengthy social media post after firing vaccine committee members Show Caption Hide Caption RFK Jr. expels entire CDC vaccine advisory committee Health Secretary Robert Kennedy Jr. removed a 17-member panel at the Centers for Disease Control and Prevention that issues recommendations on vaccines. unbranded - Newsworthy A day after abruptly firing the entire committee that advises the federal government on vaccine safety, Health and Human Services Secretary Robert F. Kennedy Jr. said he would reconstitute it with 'highly credentialed physicians and scientists' amid backlash from his detractors about the terminations. In a long post on X on June 10, Kennedy criticized the process by which the Advisory Committee for Immunization Practices recommends new vaccines, implying that "adequate safety trials" were not being conducted before recommending new vaccines to children, a notion that was strongly disputed by vaccine experts. Kennedy, who has a long record of promoting anti-vaccine views, also said the new Advisory Committee for Immunization Practices will have no 'ideological anti-vaxxers' but that the committee will apply 'evidence-based decision-making with objectivity and common sense.' 'The most outrageous example of ACIP's malevolent malpractice has been its stubborn unwillingness to demand adequate safety trials before recommending new vaccines for our children,' he wrote. Kennedy said a compliant American child receives more shots now from conception to 18 years of age compared to 1986, none of which required placebo-controlled trials. That was the year when the Vaccine Injury Compensation Program was set up, protecting vaccine makers from liability and establishing a federal program to compensate individuals injured by certain vaccines. 'This means that no one can scientifically ascertain whether these products are averting more problems than they are causing,' he wrote. A placebo-controlled study is a type of clinical trial where one group of participants receives an active treatment, while another group receives an inactive substance, helping researchers to determine whether the active treatment is truly effective. But conducting placebo-controlled studies on vaccines that are improvements on existing vaccines presents ethical and practical challenges, say vaccine experts. 'If a vaccine for a serious disease (e.g., measles, polio) already exists and is proven effective, giving participants a placebo instead of the vaccine could expose them to preventable harm or death,' wrote Dr. Jerome Adams, the former U.S. Surgeon General under President Trump's first term, in a June 9 post on X. How do vaccines work? Medical experts explain. New vaccines always undergo a placebo-controlled study, said Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia and a member of the Food and Drug Administration Vaccines and Related Biological Products Advisory Committee. But Kennedy's definition of placebo is different from FDA's, said Offit. Kennedy has sought to narrowly define placebos as salt water, said Offit, while the FDA defines it as an 'inactive substance.' 'A placebo may contain sodium sulfate or potassium sulfate or may contain sucrose, or it may contain an emulsifier – those are all generally regarded as safe,' said Offit. 'He doesn't regard them as safe.' HHS did not respond to USA TODAY seeking a comment on how Kennedy's definition differs from that of the FDA. Offit said Kennedy is a lawyer who has spent years suing pharmaceutical companies, and 'his job is to scare people about vaccines ultimately, so he can bring them back to court and sue companies,' he said. Meanwhile, in his announcement of the removal of the 17 members of the ACIP committee Kennedy said the purpose was to insulate the committee from 'conflicts of interest.'
